Published in JAMA on August 01, 2012
Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV. Circulation (2014) 3.04
Triclosan-coated sutures reduce surgical site infection after open vein harvesting in coronary artery bypass grafting patients: a randomized controlled trial. Eur J Cardiothorac Surg (2013) 2.18
Endoscopic harvesting device type and outcomes in patients undergoing coronary artery bypass surgery. Ann Surg (2014) 0.85
Endoscopic vein-graft harvest is safe for CABG surgery. JAMA (2012) 0.78
Bacterial growth and wound infection following saphenous vein harvesting in cardiac surgery: a randomized controlled trial of the impact of microbial skin sealant. Eur J Clin Microbiol Infect Dis (2014) 0.77
Strategies for the coronary surgeon to remain "competitive and co-operative" in the PCI era. Indian Heart J (2015) 0.77
Endoscopic or No-Touch Vein Harvesting for CABG: What is Best for the Patient? Braz J Cardiovasc Surg (2017) 0.75
Vein-graft harvesting technique in coronary artery bypass graft surgery. JAMA (2012) 0.75
How good is "good enough"? JAMA Surg (2013) 0.75
Response to Letters Regarding Article, "Saphenous Vein Graft Failure After Coronary Artery Bypass Surgery: Insights From PREVENT IV". Circulation (2015) 0.75
Almanac 2013: stable coronary artery disease. Wien Klin Wochenschr (2013) 0.75
Longitudinal data analysis for discrete and continuous outcomes. Biometrics (1986) 60.93
A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003. Stat Med (2008) 11.16
On-pump versus off-pump coronary-artery bypass surgery. N Engl J Med (2009) 8.85
Assessing the sensitivity of regression results to unmeasured confounders in observational studies. Biometrics (1998) 8.48
Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery. N Engl J Med (2009) 5.19
Adjusted survival curves with inverse probability weights. Comput Methods Programs Biomed (2004) 5.11
The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. Ann Thorac Surg (2009) 4.39
Impact of endoscopic versus open saphenous vein harvest techniques on outcomes after coronary artery bypass grafting. Ann Thorac Surg (2010) 3.71
Linking inpatient clinical registry data to Medicare claims data using indirect identifiers. Am Heart J (2009) 3.57
Using inverse probability-weighted estimators in comparative effectiveness analyses with observational databases. Med Care (2007) 3.53
The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. Ann Thorac Surg (2009) 3.45
Long-term outcomes of endoscopic vein harvesting after coronary artery bypass grafting. Circulation (2011) 2.44
Impact of endoscopic versus open saphenous vein harvest technique on late coronary artery bypass grafting patient outcomes in the ROOBY (Randomized On/Off Bypass) Trial. J Thorac Cardiovasc Surg (2010) 2.44
Successful linking of the Society of Thoracic Surgeons adult cardiac surgery database to Centers for Medicare and Medicaid Services Medicare data. Ann Thorac Surg (2010) 2.24
Randomized trial of endoscopic versus open vein harvest for coronary artery bypass grafting: six-month patency rates. J Thorac Cardiovasc Surg (2005) 2.19
Validity of the Society of Thoracic Surgeons National Adult Cardiac Surgery Database. Ann Thorac Surg (2004) 1.97
Endoscopic versus traditional saphenous vein harvesting: a prospective, randomized trial. Ann Thorac Surg (1998) 1.77
A prospective randomized trial of endoscopic versus conventional harvesting of the saphenous vein in coronary artery bypass surgery. J Thorac Cardiovasc Surg (2002) 1.53
Saphenous vein conduits harvested by endoscopic technique exhibit structural and functional damage. Ann Thorac Surg (2009) 1.47
Endoscopic Vascular Harvest in Coronary Artery Bypass Grafting Surgery: A Consensus Statement of the International Society of Minimally Invasive Cardiothoracic Surgery (ISMICS) 2005. Innovations (Phila) (2005) 1.47
A meta-analysis of minimally invasive versus traditional open vein harvest technique for coronary artery bypass graft surgery. Interact Cardiovasc Thorac Surg (2009) 1.32
Subcutaneous, video-assisted saphenous vein harvest: report of the first 30 cases. Cardiovasc Surg (1996) 1.28
Influence of endoscopic versus traditional saphenectomy on event-free survival: five-year follow-up of a prospective randomized trial. Heart Surg Forum (2003) 1.26
Corrected score estimation in the proportional hazards model with misclassified discrete covariates. Stat Med (2008) 1.16
A randomized trial of endoscopic versus open saphenous vein harvest in coronary bypass surgery. Ann Thorac Surg (1999) 1.04
Endoscopic vs open saphenous vein harvest for coronary artery bypass grafting: a prospective randomized trial. Eur J Cardiothorac Surg (2008) 1.01
Endoscopic saphenous vein harvesting for CABG -- a randomized, prospective trial. Thorac Cardiovasc Surg (2002) 0.97
Endoscopic saphenous vein harvesting for coronary artery bypass grafts: NICE guidance. Heart (2010) 0.87
Saphenous vein harvest with SaphLITE system versus conventional technique: a prospective, randomized study. Ann Thorac Surg (2005) 0.86
Surgery: Open or endoscopic vein graft harvesting-this is the question! Nat Rev Cardiol (2009) 0.85
Traction injury during minimally invasive harvesting of the saphenous vein is associated with impaired endothelial function. J Thorac Cardiovasc Surg (2004) 0.83
Endoscopic versus open vein-graft harvesting. N Engl J Med (2009) 0.83
Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med (2010) 32.89
Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2011) 23.50
Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med (2011) 15.70
Ethical and scientific implications of the globalization of clinical research. N Engl J Med (2009) 11.42
Large-scale pattern growth of graphene films for stretchable transparent electrodes. Nature (2009) 11.18
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med (2015) 9.70
Low diagnostic yield of elective coronary angiography. N Engl J Med (2010) 9.38
Application of new cholesterol guidelines to a population-based sample. N Engl J Med (2014) 8.22
Door-to-balloon time and mortality among patients undergoing primary PCI. N Engl J Med (2013) 8.08
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA (2006) 7.81
Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA (2009) 7.78
Human cardiac stem cells. Proc Natl Acad Sci U S A (2007) 7.76
Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med (2009) 7.71
Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med (2014) 7.23
Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA (2010) 6.91
Identifying genetic determinants needed to establish a human gut symbiont in its habitat. Cell Host Microbe (2009) 6.67
Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med (2011) 6.65
Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med (2012) 6.27
Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med (2013) 6.21
Comparative effectiveness of revascularization strategies. N Engl J Med (2012) 5.49
Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery. N Engl J Med (2009) 5.19
Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA (2013) 5.05
Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA (2007) 4.89
Apixaban with antiplatelet therapy after acute coronary syndrome. N Engl J Med (2011) 4.81
Surgical ablation of atrial fibrillation during mitral-valve surgery. N Engl J Med (2015) 4.77
2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2014) 4.57
Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med (2012) 4.47
Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med (2006) 4.44
The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. Ann Thorac Surg (2009) 4.39
Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet (2003) 4.21
Compliance with results reporting at ClinicalTrials.gov. N Engl J Med (2015) 4.17
Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA (2010) 4.13
Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol (2006) 4.11
An empirically based tool for analyzing mortality associated with congenital heart surgery. J Thorac Cardiovasc Surg (2009) 4.10
Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA (2008) 4.06
Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. JAMA (2011) 3.97
Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery. Eur J Cardiothorac Surg (2002) 3.86
Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II. Ann Intern Med (2005) 3.83
Pay for performance, quality of care, and outcomes in acute myocardial infarction. JAMA (2007) 3.79
Economic analysis of influenza vaccination and antiviral treatment for healthy working adults. Ann Intern Med (2002) 3.77
Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. JAMA (2005) 3.72
Conversion of cardiovascular conference abstracts to publications. Circulation (2012) 3.71
Association between stroke center hospitalization for acute ischemic stroke and mortality. JAMA (2011) 3.68
Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. JAMA (2012) 3.66
An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60
Linking inpatient clinical registry data to Medicare claims data using indirect identifiers. Am Heart J (2009) 3.57
Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation. J Am Coll Cardiol (2009) 3.54
Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. JAMA (2007) 3.48
Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation (2006) 3.45
The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. Ann Thorac Surg (2009) 3.45
Racial and ethnic differences in time to acute reperfusion therapy for patients hospitalized with myocardial infarction. JAMA (2004) 3.45
Sex and risk of hip implant failure: assessing total hip arthroplasty outcomes in the United States. JAMA Intern Med (2013) 3.44
Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction. JAMA (2011) 3.44
Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery. Circulation (2006) 3.38
Blood transfusion and infection after cardiac surgery. Ann Thorac Surg (2013) 3.35
Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation (2011) 3.30
Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A). J Am Coll Cardiol (2012) 3.29
Dose-ranging effects of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, as add-on to metformin in subjects with type 2 diabetes. Diabetes Care (2012) 3.28
Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation. Circulation (2013) 3.25
Association between physician billing and cardiac stress testing patterns following coronary revascularization. JAMA (2011) 3.19
Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation. N Engl J Med (2015) 3.11
Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator. JAMA (2012) 3.07
Use of aldosterone antagonists in heart failure. JAMA (2009) 3.00
Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries. JAMA (2008) 2.96
Laparoscopic versus open appendectomy: outcomes comparison based on a large administrative database. Ann Surg (2004) 2.95